Azzurra Agostini
Overview
Explore the profile of Azzurra Agostini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gatti S, Agostini A, Ferrari R, Moscatelli D
Polymers (Basel)
. 2019 Apr;
9(9).
PMID: 30965689
The control over the size distribution and stability of polymeric nanoparticles (NPs) is crucial in many of their applications, especially in the biomedical field. These characteristics are typically influenced by...
2.
Gatti S, Agostini A, Capasso Palmiero U, Colombo C, Peviani M, Biffi A, et al.
Nanotechnology
. 2018 Apr;
29(30):305602.
PMID: 29701613
An optimal drug delivery system should be characterized by biocompatibility, biodegradability, high drug loading and favorable drug release profile. To achieve this goal a hydrazone linked doxorubicin-poly(lactic acid) prodrug (PLA-DOX)...
3.
Agostini A, Capasso Palmiero U, Barbieri S, Lupi M, Moscatelli D
Nanotechnology
. 2018 Mar;
29(22):225604.
PMID: 29517488
Ibuprofen (IBU) is a widespread drug used to treat both acute and chronic disorders. It is generally taken orally but the free drug can induce the irritation of the gastric...
4.
Sironi F, Vallarola A, Violatto M, Talamini L, Freschi M, De Gioia R, et al.
Stem Cell Res
. 2017 Nov;
25:166-178.
PMID: 29154076
Stem cell therapy is considered a promising approach in the treatment of amyotrophic lateral sclerosis (ALS) and mesenchymal stem cells (MSCs) seem to be the most effective in ALS animal...
5.
Capasso Palmiero U, Agostini A, Lattuada E, Gatti S, Singh J, Canova C, et al.
Soft Matter
. 2017 Sep;
13(37):6439-6449.
PMID: 28876353
We propose a new method to produce fluorinated nanoparticles (NPs) based on ab initio reversible addition-fragmentation chain transfer (RAFT) emulsion polymerization without the use of toxic surfactants. NP size, surface...